Skip to main content
Fig. 4 | BMC Musculoskeletal Disorders

Fig. 4

From: Effects of secukinumab on bone mineral density and bone turnover biomarkers in patients with ankylosing spondylitis: 2-year data from a phase 3 study, MEASURE 1

Fig. 4

Scatter plot of change in lumbar spine BMD and mSASSS in patients with/without baseline syndesmophytes. BMD, bone mineral density; mSASSS, modified Stoke Ankylosing Spondylitis Spine Score. Horizontal line indicates change in the lumbar spine BMD of zero, and vertical line is an indicator of change in mSASSS of 2

Back to article page

BMC Musculoskeletal Disorders

ISSN: 1471-2474

Contact us